The influenza M2 ectodomain (M2e) is well conserved across human influenza A subtypes, but there are few residue changes among avian and swine origin influenza A viruses. We expressed a tandem repeat construct of heterologous M2e sequences (M2e5x) derived from human, swine, and avian origin influenza A viruses using the yeast expression system. Intramuscular immunization of mice with AS04-adjuvanted M2e5x protein vaccines was effective in inducing M2e-specific antibodies reactive to M2e peptide and native M2 proteins on the infected cells with human, swine, or avian influenza virus, mucosal and systemic memory cellular immune responses, and cross-protection against H3N2 virus. Importantly, M2e5x immune sera were found to confer protection a...
Background Influenza infection could be more effectively controlled if a multi-purpose vaccine with ...
Hemagglutinin (HA)-based current vaccines provide suboptimum cross protection. Influenza A virus con...
Background: The availability of a universal influenza vaccine able to induce broad cross-reactive im...
The influenza M2 ectodomain (M2e) is well conserved across human influenza A subtypes, but there are...
Current influenza virus vaccines are based on strain-specific surface glycoprotein hemagglutinin (HA...
Human influenza viruses are responsible for annual epidemics and occasional pandemics that cause sev...
The ectodomain of influenza matrix protein 2 (M2e) may be an ideal candidate in the development of i...
Influenza viruses constantly evolve, reducing the overall protective effect of routine vaccination c...
The influenza A virus matrix protein 2 ectodomain (M2e) is a universal influenza A vaccine candidate...
Since current influenza vaccine strategy is effective in conferring protection against vaccine strai...
The successful isolation of a human influenza virus in 1933 was soon followed by the first attempts ...
Background. A 2009 global influenza pandemic caused by a novel swine-origin H1N1 influenza A virus h...
The ectodomain of influenza A matrix protein 2 (M2e) is a candidate for a universal influenza A vacc...
The ectodomain of influenza A matrix protein 2 (M2e) is a candidate for a universal influenza A vacc...
BACKGROUND: The lack of a universal influenza vaccine is a global health problem. Interest is now fo...
Background Influenza infection could be more effectively controlled if a multi-purpose vaccine with ...
Hemagglutinin (HA)-based current vaccines provide suboptimum cross protection. Influenza A virus con...
Background: The availability of a universal influenza vaccine able to induce broad cross-reactive im...
The influenza M2 ectodomain (M2e) is well conserved across human influenza A subtypes, but there are...
Current influenza virus vaccines are based on strain-specific surface glycoprotein hemagglutinin (HA...
Human influenza viruses are responsible for annual epidemics and occasional pandemics that cause sev...
The ectodomain of influenza matrix protein 2 (M2e) may be an ideal candidate in the development of i...
Influenza viruses constantly evolve, reducing the overall protective effect of routine vaccination c...
The influenza A virus matrix protein 2 ectodomain (M2e) is a universal influenza A vaccine candidate...
Since current influenza vaccine strategy is effective in conferring protection against vaccine strai...
The successful isolation of a human influenza virus in 1933 was soon followed by the first attempts ...
Background. A 2009 global influenza pandemic caused by a novel swine-origin H1N1 influenza A virus h...
The ectodomain of influenza A matrix protein 2 (M2e) is a candidate for a universal influenza A vacc...
The ectodomain of influenza A matrix protein 2 (M2e) is a candidate for a universal influenza A vacc...
BACKGROUND: The lack of a universal influenza vaccine is a global health problem. Interest is now fo...
Background Influenza infection could be more effectively controlled if a multi-purpose vaccine with ...
Hemagglutinin (HA)-based current vaccines provide suboptimum cross protection. Influenza A virus con...
Background: The availability of a universal influenza vaccine able to induce broad cross-reactive im...